Indeed, Bifidobacterium has been found to facilitate local anti-CD47 immunotherapy on tumor tissues through the capacity to accumulate within the tumor microenvironment, via the signaling pathway of STING (Shi et al., 2020). The gene discussed is CD47; the disease is neoplasm.